Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ · Healthcare
Acadia Pharmaceuticals Inc. Total Liabilities 2009–2025
Acadia Pharmaceuticals Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Acadia Pharmaceuticals Inc. total liabilities as of December 31, 2025: 336.8M, a 25.97% decrease year-over-year.
- Acadia Pharmaceuticals Inc. total liabilities for 2025 were 336.8M, a 25.97% decrease from 2024.
- Acadia Pharmaceuticals Inc. total liabilities for 2024 were 455.0M, a 43.43% increase from 2023.
- Acadia Pharmaceuticals Inc. total liabilities for 2023 were 317.2M, a 69.27% increase from 2022.
- Acadia Pharmaceuticals Inc. total liabilities for 2022 were 187.4M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Acadia Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $337 |
| 2024 | $455 |
| 2023 | $317 |
| 2022 | $187 |
| 2021 | $159 |
| 2020 | $156 |
| 2019 | $84 |
| 2018 | $61 |
| 2017 | $49 |
| 2016 | $43 |
| 2015 | $22 |
| 2014 | $16 |
| 2013 | $7 |
| 2012 | $6 |
| 2011 | $9 |
Acadia Pharmaceuticals Inc. Total Liabilities — FAQ
Acadia Pharmaceuticals Inc. (ACAD) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACAD's total liabilities history?
The chart and table above show Acadia Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.